Naltrexone Randomized Controlled Trial for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2019
Price : $35 *
At a glance
- Drugs Naltrexone (Primary)
- Indications Fatigue
- Focus Therapeutic Use
- 31 May 2019 Status changed from active, no longer recruiting to completed.
- 08 Feb 2018 Planned primary completion date changed from 1 Aug 2018 to 1 Dec 2018.
- 29 Jul 2016 Status changed from recruiting to active, no longer recruiting.